Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Ayana Bio

Ayana Bio is a biotechnology company that produces plant and fungal bioactive ingredients for health and wellness.
2021
02-Oct
02-10
Boston, Massachusetts, United States
  • Nutraceuticals (e.g. Supplements)
  • Proteins

Innovation

Industry Problem

Rare plant and fungal bioactives are affected by agricultural variability, slow growth, climate risk, and constrained supply.

R&D Focus

Plant-cell-culture and fungal bioactive ingredients

Innovative Solution

Ayana Bio is a biotechnology company that produces plant and fungal bioactive ingredients for health and wellness.

Investment Funding

Last Funding Stage

Grant

Last Funding Date

01-05-2024

Lead Investors

National Center for Complementary and Integrative Health

Revenue

$1M to $10M

About

Ayana Bio is a biotechnology company that produces plant and fungal bioactive ingredients for health and wellness.

Products

Product

Plant Cell Advantage™ portfolio, including plant-cell-cultured dog rose, hedge nettle, sage, echinacea, lemon balm and saffron bioactives.

Star Product

Plant Cell Advantage™ platform – the company’s central scalable bioactive-production technology.

Demo Product or Complete Product?

Complete B2B ingredient/product – commercially available.

Future Plan

Market Expansion

Commercial development in North America and South Korea, with broader global ingredient partnerships.

Investment Funding

$30M Series A (2021); $1.25M BIRD Foundation support with Brevel announced in 2026.

M&A and Collabs

Collab

Ginkgo Bioworks – platform and process development for plant-cell-cultured bioactives.

Collab

Wooree Green Science – development and commercialization of saffron bioactives in South Korea.

Something missing or incorrect on this page? Help us enrich this information